Mechanistic modeling of tumor immune microenvironment reveals strategies to enhance antibody-drug conjugates’ efficacy

Constantinos Harkos, Lance L Munn, Triantafyllos Stylianopoulos, Rakesh K Jain · 2026

Read Mechanistic modeling of tumor immune microenvironment reveals strategies to enhance antibody-drug conjugates’ efficacy by Constantinos Harkos, Lance L Munn, Triantafyllos Stylianopoulos, Rakesh K Jain (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13536119.txt.

Description

Constantinos Harkos and co-authors build a math model of how antibody-drug conjugates move through a tumor and meet immune cells. These drugs pair a targeted antibody with a cell killing or immune tuning payload. The 2026 study centers on one such drug aimed at PD-L1, a protein on tumor cells.

The model folds in blood flow, fluid pressure in tissue, drug binding, and the growth of killer T cells in lymph nodes. It was fit to mouse data from two tumor types and three treatments. The model matched the finding that the paired drug beat its parts alone. It also predicts drug and cell patterns that tests did not directly track.

Catalog record

CREATORConstantinos Harkos, Lance L Munn, Triantafyllos Stylianopoulos, Rakesh K Jain
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13536119

Browse the full library · About the Tower of Babel